Eli Lilly and Company (LLY)

Fixed asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 45,042,700 40,863,300 38,922,800 35,932,100 34,124,100 32,072,500 29,515,500 27,691,400 28,541,400 29,239,500 29,070,700 29,322,800 28,318,400 27,758,500 26,726,300 25,485,600 24,539,800 23,213,800 22,949,800 23,087,100
Property, plant and equipment US$ in thousands 17,102,400 16,171,800 14,829,400 13,624,000 12,913,600 11,863,200 11,277,400 10,546,200 10,144,000 9,311,300 9,128,200 9,102,700 8,985,100 8,920,400 8,855,500 8,630,100 8,681,900 8,281,100 7,981,100 7,897,900
Fixed asset turnover 2.63 2.53 2.62 2.64 2.64 2.70 2.62 2.63 2.81 3.14 3.18 3.22 3.15 3.11 3.02 2.95 2.83 2.80 2.88 2.92

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $45,042,700K ÷ $17,102,400K
= 2.63

Fixed asset turnover measures how efficiently a company generates sales using its fixed assets. A higher fixed asset turnover indicates that the company is effectively utilizing its fixed assets to generate revenue.

Based on the provided data for Eli Lilly and Company, the fixed asset turnover ratio has shown some fluctuations over the years. From March 31, 2020, to December 31, 2022, the ratio ranged between 2.80 and 3.22, indicating a relatively stable and efficient use of fixed assets to generate sales.

However, there was a slight decline in the ratio in the following periods, reaching a low of 2.53 on September 30, 2024. This may suggest a decrease in the efficiency of utilizing fixed assets to generate revenue during that period.

Overall, the trend of Eli Lilly and Company's fixed asset turnover ratio shows some variability but generally reflects a consistent and efficient utilization of fixed assets in generating sales over the years. Further analysis of the company's operational and strategic initiatives may provide more insights into the factors influencing these fluctuations.


See also:

Eli Lilly and Company Net Fixed Asset Turnover (Quarterly Data)